Clinical Trial Update: The Effect of Prophylactic TPO Combined with BMS-IMRT to Esophageal Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial completed evaluating prophylactic thrombopoietin combined with BMS-IMRT in esophageal cancer patients. The study addresses thrombocytopenia during…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Thrombopoietin (thrombopoietin)

Snippet

Sponsor: JIANYANG WANG | Conditions: Esophageal Cancer, Intensity-modulated Radiation Therapy | Phase 2 | Status: COMPLETED